Combination Paclitaxel, Carboplatin and Temozolomide
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the maximum tolerable dose of temozolomide in
combination with fixed dose of paclitaxel and carboplatin and to determine the overall tumor
response rate with this combination and to determine the duration of response.